on O3 Holding GmbH (isin : NO0013360552)
O3 Holding GmbH Releases Q4 2025 Interim Report
O3 Holding GmbH, the holding company for KD Pharma Group, has announced the publication of its Q4 2025 Interim Report. This release is part of the conditions for the company's FRN Senior Secured EUR 180,000,000 bond, under ISIN NO0013360552, originally issued on 28 October 2024. The report has been made publicly available on KD Pharma Group's website.
The publication of the Q4 2025 Interim Report marks a key regulatory requirement for O3 Holding GmbH. Investors can access detailed financial results and corporate developments via the company's online investor relations portal.
O3 Holding GmbH, located in Bexbach, Germany, continues to operate within the regulated unofficial market in Frankfurt. Stakeholders seeking further information can contact the company through the provided investor relations email.
R. P.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all O3 Holding GmbH news